R&D News | pharmaphorum

News

IFPMA’s new code bans all gifts – no exceptions!

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has published its new code of practice, introducing a total ban on gifts and promotional items for pres

News

Daiichi Sankyo takes option on diabetes stem cell start-up

Japan’s Daiichi Sankyo has joined an open innovation research initiative that will try to develop a therapy for type 1 diabetes based on insulin-producing cells.

News

Close up view of young woman holding ginseng vitamins and minerals pills in hand with capsule bottle on table. High angle view

HRT tablets linked to higher blood clot risk: study

Certain types of hormone replacement therapy (HRT) could lead to increased risk of venous thromboembolism (VTE), a new study has suggested.

News

Sage soars on postpartum depression data

Sage Therapeutics has scored a big win with postpartum depression (PPD) drug SAGE-217, after rolling the dice on an upgraded clinical trial last summer.

News